Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 1;52(4):607-617.
doi: 10.1097/CCM.0000000000006106. Epub 2023 Nov 15.

Association of Early Dexmedetomidine Utilization With Clinical and Functional Outcomes Following Moderate-Severe Traumatic Brain Injury: A Transforming Clinical Research and Knowledge in Traumatic Brain Injury Study

Collaborators, Affiliations

Association of Early Dexmedetomidine Utilization With Clinical and Functional Outcomes Following Moderate-Severe Traumatic Brain Injury: A Transforming Clinical Research and Knowledge in Traumatic Brain Injury Study

Sunny Yang Liu et al. Crit Care Med. .

Abstract

Objective: To examine early sedation patterns, as well as the association of dexmedetomidine exposure, with clinical and functional outcomes among mechanically ventilated patients with moderate-severe traumatic brain injury (msTBI).

Design: Retrospective cohort study with prospectively collected data.

Setting: Eighteen Level-1 Trauma Centers, United States.

Patients: Adult (age > 17) patients with msTBI (as defined by Glasgow Coma Scale < 13) who required mechanical ventilation from the Transforming Clinical Research and Knowledge in TBI (TRACK-TBI) study.

Interventions: None.

Measurements and main results: Using propensity-weighted models, we examined the association of early dexmedetomidine exposure (within the first 5 d of ICU admission) with the primary outcome of 6-month Glasgow Outcomes Scale Extended (GOS-E) and the following secondary outcomes: length of hospital stay, hospital mortality, 6-month Disability Rating Scale (DRS), and 6-month mortality. The study population included 352 subjects who required mechanical ventilation within 24 hours of admission. The initial sedative medication was propofol for 240 patients (68%), midazolam for 59 patients (17%), ketamine for 6 patients (2%), dexmedetomidine for 3 patients (1%), and 43 patients (12%) never received continuous sedation. Early dexmedetomidine was administered in 77 of the patients (22%), usually as a second-line agent. Compared with unexposed patients, early dexmedetomidine exposure was not associated with better 6-month GOS-E (weighted odds ratio [OR] = 1.48; 95% CI, 0.98-2.25). Early dexmedetomidine exposure was associated with lower DRS (weighted OR = -3.04; 95% CI, -5.88 to -0.21). In patients requiring ICP monitoring within the first 24 hours of admission, early dexmedetomidine exposure was associated with higher 6-month GOS-E score (OR 2.17; 95% CI, 1.24-3.80), lower DRS score (adjusted mean difference, -5.81; 95% CI, -9.38 to 2.25), and reduced length of hospital stay (hazard ratio = 1.50; 95% CI, 1.02-2.20).

Conclusion: Variation exists in early sedation choice among mechanically ventilated patients with msTBI. Early dexmedetomidine exposure was not associated with improved 6-month functional outcomes in the entire population, although may have clinical benefit in patients with indications for ICP monitoring.

PubMed Disclaimer

Conflict of interest statement

Dr. Temkin’s institution received funding from the National Institute of Neurological Disorders and Stroke (NINDS), Abbott, and the U.S. Federal Government; she received funding from Bristol-Myers-Squibb, the Medical College of Wisconsin, Neurotrauma Sciences, and Novartis. Drs. Temkin and Markowitz’s institutions received funding from the U.S. Department of Defense (DoD). Drs. Temkin, Komisarow, Manley, Vavilala, and Krishnamoorthy received support for article research from the National Institutes of Health. Dr. Manley’s institution received funding from NINDS (U01NS086090). Dr. Markowitz received support for article research from the U.S. DoD. Dr. Krishnamoorthy’s institution received funding from NINDS (K23NS109274). The remaining authors have disclosed that they do not have any potential conflicts of interest.

Figures

Figure 1:
Figure 1:
Study flowchart. GCS, Glasgow Coma Scale; ICU, Intensive Care Unit; TBI, Traumatic Brain Injury. 352 subjects met the inclusion criteria from an initial 2697 patients in the TRACK-TBI cohort.
Figure 2:
Figure 2:
Area proportional Venn diagram of total sedative use in the first 5 days
Figure 3.
Figure 3.
Weighted cumulative survival by 6 months, comparing patients who received early dexmedetomidine treatment and those who did not. Dex, dexmedetomidine.

Comment in

References

    1. Dewan MC, Rattani A, Gupta S, et al. Estimating the global incidence of traumatic brain injury. J Neurosurg 2018:1–18. DOI: 10.3171/2017.10.JNS17352. - DOI - PubMed
    1. Krishnamoorthy V, Temkin N, Barber J, et al. Association of Early Multiple Organ Dysfunction With Clinical and Functional Outcomes Over the Year Following Traumatic Brain Injury: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study. Crit Care Med 2021;49(10):1769–1778. DOI: 10.1097/CCM.0000000000005055. - DOI - PMC - PubMed
    1. Devlin JW, Skrobik Y, Gelinas C, et al. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med 2018;46(9):e825–e873. DOI: 10.1097/CCM.0000000000003299. - DOI - PubMed
    1. Flower O, Hellings S. Sedation in traumatic brain injury. Emerg Med Int 2012;2012:637171. DOI: 10.1155/2012/637171. - DOI - PMC - PubMed
    1. Roberts DJ, Hall RI, Kramer AH, Robertson HL, Gallagher CN, Zygun DA. Sedation for critically ill adults with severe traumatic brain injury: a systematic review of randomized controlled trials. Crit Care Med 2011;39(12):2743–51. DOI: 10.1097/CCM.0b013e318228236f. - DOI - PubMed

Publication types

MeSH terms